U

UMediC Group Bhd
KLSE:UMC

Watchlist Manager
UMediC Group Bhd
KLSE:UMC
Watchlist
Price: 0.605 MYR
Market Cap: 226.2m MYR
Have any thoughts about
UMediC Group Bhd?
Write Note
Section:
 
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

UMC Price Targets Summary
UMediC Group Bhd

Wall Street analysts forecast UMC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for UMC is 0.802 MYR with a low forecast of 0.697 MYR and a high forecast of 0.924 MYR.

UMC Lowest Forecast
Wall Street Target
0.697 MYR
15% Upside
UMC Average Forecast
Wall Street Target
0.802 MYR
33% Upside
UMC Highest Forecast
Wall Street Target
0.924 MYR
53% Upside
Lowest
Price Target
0.697 MYR
15% Upside
Average
Price Target
0.802 MYR
33% Upside
Highest
Price Target
0.924 MYR
53% Upside
UMediC Group Bhd Competitors:
Price Targets
PDCO
Patterson Companies Inc
3% Downside
AMP
Amplifon SpA
25% Upside
PGC
Paragon Care Ltd
16% Upside
SELEC.E
Selcuk Ecza Deposu Ticaret ve Sanayi AS
4% Upside
PDCO
Patterson Companies Inc
3% Downside
AMP
Amplifon SpA
25% Upside
PGC
Paragon Care Ltd
16% Upside
SELEC.E
Selcuk Ecza Deposu Ticaret ve Sanayi AS
4% Upside
GALE
Galenica AG
4% Upside

Revenue
Forecast

Revenue Estimate
UMediC Group Bhd

For the last 4 years the compound annual growth rate for UMediC Group Bhd's revenue is 23%. The projected CAGR for the next 3 years is 20%.

23%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-18%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
UMediC Group Bhd

For the last 4 years the compound annual growth rate for UMediC Group Bhd's operating income is 38%. The projected CAGR for the next 3 years is 26%.

38%
Past Growth
26%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
UMediC Group Bhd

For the last 4 years the compound annual growth rate for UMediC Group Bhd's net income is 39%. The projected CAGR for the next 3 years is 28%.

39%
Past Growth
28%
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

See Also

Summary
UMC intrinsic value, competitors valuation, and company profile.
DCF Valuation
UMC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
UMC stock valuation using valuation multiples.
Wall Street Estimates
UMC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
UMC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is UMC's stock price target?
Price Target
0.802 MYR

According to Wall Street analysts, the average 1-year price target for UMC is 0.802 MYR with a low forecast of 0.697 MYR and a high forecast of 0.924 MYR.

What is UMediC Group Bhd's Revenue forecast?
Projected CAGR
20%

For the last 4 years the compound annual growth rate for UMediC Group Bhd's revenue is 23%. The projected CAGR for the next 3 years is 20%.

What is UMediC Group Bhd's Operating Income forecast?
Projected CAGR
26%

For the last 4 years the compound annual growth rate for UMediC Group Bhd's operating income is 38%. The projected CAGR for the next 3 years is 26%.

What is UMediC Group Bhd's Net Income forecast?
Projected CAGR
28%

For the last 4 years the compound annual growth rate for UMediC Group Bhd's net income is 39%. The projected CAGR for the next 3 years is 28%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 215,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.